About this program
EnrollDate
Self Paced
Occasions
Learn at your own pace (4 hours)
Place
Online
Language
English
Price
100 CAD + tax
Facilitators
Course description
This course will bring you on a journey through the effects elicited by psilocybin on the body and mind as it relates to psychedelic-assisted therapy.
The content developed for this course is based on current literature and research and analyzed through the lens of trauma and violence-informed care and through commitments to social justice, equity, dignity, inclusion, cultural safety, and humility.
In the course, you will learn about the dose ranges, indications, contraindications, and concomitant medications of psilocybin. You will also learn about some fundamental pharmacology and neurobiology as it relates to the administration of psilocybin in psychedelic-assisted therapy.
This course has been approved for continuing education credits through the Canadian Psychological Association (CPA), l’Ordre des psychologues du Québec (OPQ), the Canadian Counselling and Psychotherapy Association (CCPA), and the National Board for Certified Counselors (NBCC). This is applicable to regulated professionals.
This course can be completed at your own pace whenever it is most convenient for you, however the course must be completed within 1 year of your registration date. If the course is not completed after 1 year, you will not be eligible for a refund, and you will need to re-register.
Prerequisites
There are no prerequisites for this course.
Continuing Education Credits
This program has been approved for 4 CE credits by CPA, CCPA, OPQ, and NBCC.
Program Agenda
Please download the program agenda to see the time commitment for each module.
Content Overview
Please use the arrows below to learn more about what will be taught in each module.
Topics
• Trauma psychobiology
• Neurotransmitters
• Neuroplasticity
• Pharmacodynamics
• Pharmacokinetics
• Traditional mental health pharmacotherapy
• Comparing psychedelic medicines and properties
Learning Outcomes
• Describe the role of neurotransmitters in the body and brain.
• Explain the difference between pharmacokinetics and pharmacodynamics.
• Explain the general mechanism of action of traditional pharmacopsychotherapy.
• Define the various categories of psychotropic substances within the context of psychedelic-assisted therapy.
• Distinguish between an effect and a side effect for the purposes of client education.
• Compare the differences and similarities between psilocybin, MDMA, and ketamine for the purposes of psychedelic-assisted therapy.
Topics
• Molecular structure of the medicine(s)
• History of the medicine(s)
• Legal status of the medicine(s)
Learning Outcomes
• Describe the molecular structure of psilocybin.
• Describe the subjective and physiological effects and side effects of psilocybin according to different dose ranges as they relate to psychedelic-assisted therapy.
• Explain the primary effects and mechanisms of action of psilocybin on the brain, including connectivity in the brain and activation of serotonin receptors.
• List key historical events that led to the usage of psilocybin in psychedelic-assisted therapy.
• Identify the current legal status of silocybin in Canada and the United States.
• Discuss the need to uphold cultural safety and humility within an Indigenous context.
Topics
• Indications treated with the medicine(s)
• Key studies on psychedelic-assisted therapy
• Anesthetic vs psychedelic vs psycholytic vs microdoses dose ranges and effects
• Mechanisms of action
Learning Outcomes
• Explain the risks, benefits, and pharmacological knowledge of psilocybin in plain language to interdisciplinary colleagues and to clients as part of the informed consent process.
• Describe recommended dosages, expected duration, metabolism, and expected intensity of psilocybin.
• Discuss key areas of research on psilocybin.
• Explain the pharmacodynamics and pharmacokinetics of psilocybin.
• Describe the subjective and physiological effects and side effects of psilocybin according to different dose ranges as they relate to psychedelic-assisted therapy.
• Explain the primary effects and mechanisms of action of psilocybin on the brain, including connectivity in the brain and activation of serotonin receptors.
• Explain for which indications psilocybin is used.
Topics
• Side effects
• Harm reduction
• Topics important for consent
• Contraindications
• Concomitant medications and supplements
Learning Outcomes
• Explain the risks, benefits, and pharmacological knowledge of psilocybin in plain language to interdisciplinary colleagues and to clients as part of the informed consent process.
• Describe the subjective and physiological effects and side effects of psilocybin according to different dose ranges as they relate to psychedelic-assisted therapy.
• Describe the contraindications and concomitant medications of psilocybin in order to determine client suitability for psychedelic-assisted therapy.
• Identify models of substance use, potential for addiction, and opportunities for recovery for psilocybin.
Learning Outcomes
After the course, you’ll be able to:
-
Apply pharmacological knowledge of psilocybin to the facilitation or development of a psychedelic-assisted therapy protocol in a clinical setting.
-
Compare the wide range of effects, side effects, effects of long-term use, and abuse potential of psilocybin.
-
Apply cultural safety and humility to the administration of psilocybin as part of psilocybin-assisted therapy in order to avoid cultural appropriation and cultural harm.
-
Screen clients and determine if psilocybin would be best suited for a given client or clinical presentation.
Disclaimer
The continuing professional development program in no way promotes, condones, or facilitates illegal activity, and is strictly for educational and harm reduction purposes only. Please be aware that certain psychedelic substances still remain illegal in many jurisdictions, including Canada. This program and the contents of this website do not constitute medical advice and are not a substitute for professional medical advice and treatment.
FAQs
No, there are no prerequisites.
Yes – for 4 hours
No – the Molecular Foundations courses are entirely asynchronous and can be completed on your own schedule.
If you are providing or interested in providing psychedelic services to clients in any capacity, our programs will build on your skillset and benefit your practice. Our programs are open to a diverse set of professionals such as psychologists, social workers, psychotherapists, and other health professionals who are looking to add credibility, experience, and a robust skillset for providing psychedelic services.
Yes – absolutely
Yes, this course is recognized by the following organizations for continuing education credit.
Canadian Psychological Association
4 credit hours
Canadian Counselling and Psychotherapy Association
4 credit hours
L’Ordre des psychologues du Québec
4 credit hours
National Board for Certified Counselors
3 credit hours
Numinus Wellness has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7360. Programs that do not qualify for NBCC credit are clearly identified. Numinus Wellness is solely responsible for all aspects of the programs.
We’re happy to help. Send us an e-mail at training@numinus.com
If you are unable to attend the course, please send an e-mail confirming your cancellation to training@numinus.com. A 10% administration fee will be charged for any cancellations, based on the total cost of the course, plus tax. All cancellations need to be processed at least 24 business hours prior to the start of the training program for a refund to occur. Cancellations that occur less than 24 hours will be subject to no refund. Alternatively, credits for future courses may be applied and used within one calendar year. Refunds will be processed within 7 business days from cancellation. If you have any questions, please reach out to our team and we would be happy to support you.
To request an accessibility accommodation, please email us at training@numinus.com for support.
You must attend all 8 live sessions, complete all 8 pre-work modules and their corresponding knowledge checks (achieving 80% or higher), submit three written assignments (with the option to submit a video if preferred), complete all 8 practice group sessions, and fill out a course satisfaction survey before you can download the certificate.
You can join the course from a desktop, laptop, tablet, or mobile device. To access Numinus’ training platform, you must meet these minimum requirements.
Once you have completed all course requirements, you will receive a notification via email that you are eligible to download your certificate. You can then log into Numinus’ Training platform and download your certificate.
